Showing results (471-480 of 3,788) with videos related to
Sort By:
Pageof 379
Oncoimmunology|September 28, 2013
Myeloid-derived suppressor cells in allogeneic hematopoietic stem cell transplantation: A double-edged sword?Katarina Le Blanc, Regina Jitschin, Dimitrios MougiakakosOncoimmunology|September 28, 2013
Injection site and regulatory T cells influence durable vaccine-induced tumor immunity to an over-expressed self tumor associated antigenJennifer D Bright, Heather N Schultz, Jennifer A Byrne, et al.Oncoimmunology|October 2, 2013
Myeloid-derived suppressor cells as a Trojan horse: A cellular vehicle for the delivery of oncolytic virusesPing-Ying Pan, Hui-Ming Chen, Shu-Hsia ChenOncoimmunology|October 2, 2013
How the devil facial tumor disease escapes host immune responsesHannah V Siddle, Jim KaufmanOncoimmunology|October 2, 2013
Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8+ T-cell responses to anticancer vaccinesByram W Bridle, Derek Clouthier, Liang Zhang, et al.Oncoimmunology|July 30, 2013
Engineering Grp170-based immune modulators for cancer immunotherapyXiaofei Yu, Xiang-Yang WangOncoimmunology|July 30, 2013
Use of a KIT-specific monoclonal antibody to bypass imatinib resistance in gastrointestinal stromal tumorsBadreddin Edris, Stephen Willingham, Kipp Weiskopf, et al.Oncoimmunology|July 30, 2013
An apolipoprotein A-I mimetic targets scavenger receptor A on tumor-associated macrophages: A prospective anticancer treatment?Claudine Neyen, Subhankar Mukhopadhyay, Siamon Gordon, et al.Oncoimmunology|July 30, 2013
BRAF-targeted therapy and immune responses to melanomaShin Foong Ngiow, Deborah A Knight, Antoni Ribas, et al.Oncoimmunology|July 30, 2013
ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapyYuting Ma, Sandy Adjemian, Heng Yang, et al.Pageof 379